Hyperlipidemia: Clinical Trials

2 trials for Hyperlipidemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Terminated 2
Phase 21Terminated 1

Follow Hyperlipidemia: new trials by email Literature Review of Hyperlipidemia trials Research Report on Hyperlipidemia

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PK Study of YH22189 FDC Compared to Combination of Telmisartan/Amlodipine and Rosuvastatin
YH22189, Twynsta 80/10mg, Crestor 20mg - Hypertension, Hyperlipidemia
Phase 1TerminatedYuhan Corporation1232015-11-012017-02-01
IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia
Atorvastatin - HIV Infections, Hyperlipidemia
Phase 1 / Phase 2TerminatedInternational Maternal Pediatric Adolescent AIDS Clinical Trials Group282009-08-012016-04-06

Narrower conditions

Hyperlipidemias (2)  ·  HIV Infections (1)  ·  Hypertension (1)

Broader conditions

Dyslipidemias (2)  ·  Lipid Metabolism Disorders (2)  ·  Metabolic Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Blood-Borne Infections (1)  ·  Cardiovascular Diseases (1)  ·  Communicable Diseases (1)  ·  Genital Diseases (1)  ·  Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Infections (1)  ·  Lentivirus Infections (1)  ·  RNA Virus Infections (1)  ·  Retroviridae Infections (1)  ·  Sexually Transmitted Diseases (1)

Interventions

Amlodipine (1)  ·  Atorvastatin (1)  ·  Rosuvastatin Calcium (1)  ·  Telmisartan (1)  ·  telmisartan amlodipine combination (1)

Sponsors

International Maternal Pediatric Adolescent AIDS Clinical Trials Group (1)  ·  Yuhan Corporation (1)

Countries

South Korea (1)  ·  United States (1)

Top investigators

Ann Melvin, MD (1)  ·  Marilyn Crain, MD, MPH (1)

NIH funding

U01AI068632 (1)